People's United Financial’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-17,000
Closed -$565K – 744
2017
Q4
$565K Hold
17,000
– – 0.02% 495
2017
Q3
$560K Sell
17,000
-150
-0.9% -$3.38K 0.02% 426
2017
Q2
$339K Buy
17,150
+560
+3% +$10.8K 0.01% 542
2017
Q1
$320K Hold
16,590
– – 0.01% 544
2016
Q4
$308K Sell
16,590
-350
-2% -$6.69K 0.01% 523
2016
Q3
$237K Hold
16,940
– – 0.01% 419
2016
Q2
$136K Buy
16,940
+1,500
+10% +$16.6K 0.01% 450
2016
Q1
$167K Buy
+15,440
New +$198K 0.01% 453

Other funds holding RGNX

People's United Financial's RGNX Position: Q1 2018 in Review

People's United Financial sold out of Regenxbio (RGNX) in Q1 2018, closing a stake of 17,000 shares — an estimated $565K sold.

People's United Financial first reported a position in RGNX in Q1 2016 and held it in 8 quarters. The position peaked at $565K in Q4 2017. 120 funds tracked by Wall St. Rank hold RGNX as of Q1 2018.

  • People's United Financial reported no remaining Regenxbio position as of Q1 2018 after selling out during the quarter.
  • People's United Financial sold 17,000 Regenxbio shares in Q1 2018, an estimated $565K.
  • People's United Financial first reported a position in Regenxbio in Q1 2016 and held it in 8 quarters.
  • People's United Financial's Regenxbio position peaked at $565K in Q4 2017.
  • 120 funds tracked by Wall St. Rank held Regenxbio as of Q1 2018.

Based on People's United Financial's 13F filing for Q1 2018, filed 15 May 2018.